Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Invest Dermatol. 2014 Nov;134(11):2839-42. doi: 10.1038/jid.2014.248. Epub 2014 Jun 16.

DC-HIL+ CD14+ HLA-DR no/low cells are a potential blood marker and therapeutic target for melanoma.

Author information

  • 1Department of Dermatology, The University of Texas Southwestern Medical Center and Dermatology Section (Medical Service), Dallas Veterans Affairs Medical Center, Dallas, Texas, USA.
  • 2Departments of Oncology and Surgery, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • 3The University of Texas Southwestern Medical Center, Dallas, Texas, USA.
PMID:
24933321
[PubMed - indexed for MEDLINE]
PMCID:
PMC4199894
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk